Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Inagaki

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Viruses|January 8, 2025
The Role of vIL-6 in KSHV-Mediated Immune Evasion and TumorigenesisSomayeh Komaki, Tomoki Inagaki, Ashish Kumar, et al.
Journal of Virology|January 19, 2024
Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradationKen-Ichi Nakajima, Tomoki Inagaki, Jonna Magdallene Espera, et al.
Virology|June 23, 2024
An atlas of chromatin landscape in KSHV-infected cells during de novo infection and reactivationTomoki Inagaki, Ashish Kumar, Somayeh Komaki, et al.
Viruses|December 28, 2021
Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic ReactivationTakayuki Murata, Atsuko Sugimoto, Tomoki Inagaki, et al.
Journal of Virology|January 19, 2024
Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promotersYoshihiro Izumiya, Adhraa Algalil, Jonna M Espera, et al.
Plos Pathogens|October 26, 2023
Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophagesMichiko Shimoda, Tomoki Inagaki, Ryan R Davis, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
KSHV uses viral IL6 to expand infected immunosuppressive macrophagesMichiko Shimoda, Tomoki Inagaki, Ryan R Davis, et al.
Journal of Virology|July 22, 2022
KSHV Topologically Associating Domains in Latent and Reactivated Viral ChromatinMel Campbell, Chanikarn Chantarasrivong, Yuichi Yanagihashi, et al.
Plos Pathogens|February 1, 2024
Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulationKen Sagou, Yoshitaka Sato, Yusuke Okuno, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseasesTomoki Inagaki, Jonna Espera, Kang-Hsin Wang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Viruses|January 8, 2025
The Role of vIL-6 in KSHV-Mediated Immune Evasion and TumorigenesisSomayeh Komaki, Tomoki Inagaki, Ashish Kumar, et al.
Journal of Virology|January 19, 2024
Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradationKen-Ichi Nakajima, Tomoki Inagaki, Jonna Magdallene Espera, et al.
Virology|June 23, 2024
An atlas of chromatin landscape in KSHV-infected cells during de novo infection and reactivationTomoki Inagaki, Ashish Kumar, Somayeh Komaki, et al.
Viruses|December 28, 2021
Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic ReactivationTakayuki Murata, Atsuko Sugimoto, Tomoki Inagaki, et al.
Journal of Virology|January 19, 2024
Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promotersYoshihiro Izumiya, Adhraa Algalil, Jonna M Espera, et al.
Plos Pathogens|October 26, 2023
Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophagesMichiko Shimoda, Tomoki Inagaki, Ryan R Davis, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
KSHV uses viral IL6 to expand infected immunosuppressive macrophagesMichiko Shimoda, Tomoki Inagaki, Ryan R Davis, et al.
Journal of Virology|July 22, 2022
KSHV Topologically Associating Domains in Latent and Reactivated Viral ChromatinMel Campbell, Chanikarn Chantarasrivong, Yuichi Yanagihashi, et al.
Plos Pathogens|February 1, 2024
Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulationKen Sagou, Yoshitaka Sato, Yusuke Okuno, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseasesTomoki Inagaki, Jonna Espera, Kang-Hsin Wang, et al.
Pageof 3